Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 01, 2019

BUY
$0.54 - $1.33 $1,080 - $2,660
2,000 Added 14.29%
16,000 $12,000
Q1 2019

May 08, 2019

BUY
$1.1 - $1.76 $15,400 - $24,640
14,000 New
14,000 $18,000
Q1 2018

Apr 10, 2018

SELL
$0.91 - $1.73 $1,183 - $2,249
-1,300 Closed
0 $0
Q3 2017

Oct 16, 2017

BUY
$1.54 - $1.85 $2,002 - $2,405
1,300
1,300 $2,000

Others Institutions Holding VTGN

About VistaGen Therapeutics, Inc.


  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $730M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Hartford Financial Management Inc. Portfolio

Follow Hartford Financial Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Financial Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hartford Financial Management Inc. with notifications on news.